The drug interaction potential of ranitidine: an update
- PMID: 1763135
- DOI: 10.1016/0163-7258(91)90015-e
The drug interaction potential of ranitidine: an update
Abstract
Ranitidine is a H2-receptor antagonist widely used in the treatment of a variety of gastrointestinal disorders. Since cimetidine--the predecessor drug of ranitidine--interacts with a variety of other agents and moreover ranitidine is often administered in combination with other drugs the interaction potential of ranitidine has been subject to extensive investigations. This review updates the information available from 1988 to present. Pharmacokinetic interactions of ranitidine with other drugs may occur at the site of absorption, metabolism and renal excretion. Most of the interactions reported at each of the three levels are minor and of low clinical significance. In view of some uncontrolled anecdotal reports, one cannot completely rule out the possibility that ranitidine might have some limited interaction potential in special patient populations under certain clinical conditions. However, it must be emphasized that numerous controlled studies have proven that ranitidine can be safely coadministered with other drugs.
Similar articles
-
The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.J Clin Gastroenterol. 1983;5 Suppl 1:95-113. doi: 10.1097/00004836-198312001-00010. J Clin Gastroenterol. 1983. PMID: 6140286 Review.
-
Interactions and non-interactions with ranitidine.Clin Pharmacokinet. 1984 Nov-Dec;9(6):493-510. doi: 10.2165/00003088-198409060-00002. Clin Pharmacokinet. 1984. PMID: 6096071 Review.
-
Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.Clin Pharmacol Ther. 1988 Oct;44(4):442-52. doi: 10.1038/clpt.1988.178. Clin Pharmacol Ther. 1988. PMID: 2901930
-
Effect of cimetidine and ranitidine on cardiovascular drugs.Am Heart J. 1989 Jul;118(1):144-54. doi: 10.1016/0002-8703(89)90085-9. Am Heart J. 1989. PMID: 2662728 Review.
-
Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.Clin Pharmacokinet. 1988 Jul;15(1):44-56. doi: 10.2165/00003088-198815010-00004. Clin Pharmacokinet. 1988. PMID: 3042245 Review.
Cited by
-
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004. Clin Pharmacokinet. 1996. PMID: 8896944 Review.
-
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.Clin Pharmacokinet. 1996 Oct;31(4):257-74. doi: 10.2165/00003088-199631040-00003. Clin Pharmacokinet. 1996. PMID: 8896943 Review.
-
Pharmacokinetic considerations in the eradication of Helicobacter pylori.Clin Pharmacokinet. 2000 Mar;38(3):243-70. doi: 10.2165/00003088-200038030-00004. Clin Pharmacokinet. 2000. PMID: 10749519 Review.
-
Safety of acid-suppressing drugs.Dig Dis Sci. 1995 Feb;40(2 Suppl):63S-80S. doi: 10.1007/BF02214872. Dig Dis Sci. 1995. PMID: 7859585 Review.
-
Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet. 1994 Dec;27(6):462-85. doi: 10.2165/00003088-199427060-00005. Clin Pharmacokinet. 1994. PMID: 7882636 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources